IL6 and type 2 diabetes mellitus: Moreover, a dysregulated immune system in patients with type 2 diabetes and chronic inflammation accompanied with elevated cytokine levels such as interleukin-6, tumor necrosis factor-α, and C-reactive protein could promote CRC tumorigenesis.37